These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 28598776

  • 1. Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules.
    Houlder EL, Millier MJ, Highton J, Gwynne-Jones D, Stamp LK, Hessian PA.
    Clin Exp Rheumatol; 2017; 35(6):943-947. PubMed ID: 28598776
    [Abstract] [Full Text] [Related]

  • 2. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
    Stamp LK, Hazlett J, Highton J, Hessian PA.
    J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
    [Abstract] [Full Text] [Related]

  • 3. The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.
    Soukup T, Dosedel M, Nekvindova J, Antonin Kubena A, Tacheci I, Duintjer Tebbens J, Vlcek J, Bradna P, Barvik I, Pavek P.
    Pharmacogenet Genomics; 2017 Feb; 27(2):43-50. PubMed ID: 27846189
    [Abstract] [Full Text] [Related]

  • 4. Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action.
    Stamp LK, Hazlett J, Roberts RL, Frampton C, Highton J, Hessian PA.
    Arthritis Res Ther; 2012 Jun 08; 14(3):R138. PubMed ID: 22682496
    [Abstract] [Full Text] [Related]

  • 5. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, Keskes L, Fourati H, Bahloul Z, Maalej A.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 08; 41(4):385-93. PubMed ID: 26077125
    [Abstract] [Full Text] [Related]

  • 6. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.
    Kerstens PJ, Boerbooms AM, Jeurissen ME, Fast JH, Assmann KJ, van de Putte LB.
    J Rheumatol; 1992 Jun 08; 19(6):867-71. PubMed ID: 1404122
    [Abstract] [Full Text] [Related]

  • 7. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug 08; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 8. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
    Kato T, Hamada A, Mori S, Saito H.
    Drug Metab Pharmacokinet; 2012 Aug 08; 27(2):192-9. PubMed ID: 22104130
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of methotrexate induced nodulosis with D-penicillamine.
    Dash S, Seibold JR, Tiku ML.
    J Rheumatol; 1999 Jun 08; 26(6):1396-9. PubMed ID: 10381063
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.
    Muralidharan N, Gulati R, Misra DP, Negi VS.
    Clin Exp Med; 2018 Feb 08; 18(1):101-107. PubMed ID: 28821984
    [Abstract] [Full Text] [Related]

  • 12. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
    Singh A, Misra R, Aggarwal A.
    Rheumatol Int; 2019 Aug 08; 39(8):1431-1438. PubMed ID: 31203399
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N.
    Int J Mol Med; 2003 May 08; 11(5):593-600. PubMed ID: 12684695
    [Abstract] [Full Text] [Related]

  • 14. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.
    Segal R, Caspi D, Tishler M, Fishel B, Yaron M.
    Arthritis Rheum; 1988 Sep 08; 31(9):1182-5. PubMed ID: 3422015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis.
    Falcini F, Taccetti G, Ermini M, Trapani S, Calzolari A, Franchi A, Cerinic MM.
    Arthritis Rheum; 1997 Jan 08; 40(1):175-8. PubMed ID: 9008613
    [Abstract] [Full Text] [Related]

  • 17. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis.
    Williams FM, Cohen PR, Arnett FC.
    J Am Acad Dermatol; 1998 Aug 08; 39(2 Pt 2):359-62. PubMed ID: 9703153
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P, Salazar J, Arranz MJ, Díaz-Torné C, del Río E, Casademont J, Corominas H, Baiget M.
    Pharmacogenomics; 2016 Aug 08; 17(1):25-9. PubMed ID: 26652611
    [Abstract] [Full Text] [Related]

  • 19. Rheumatoid nodules located in the penis of a methotrexate-treated patient with rheumatoid arthritis.
    Essig KM, Mayet WJ, Mottrie AM, Helmreich-Becker I, Meyer zum Büschenfelde KH.
    Z Rheumatol; 1994 Aug 08; 53(5):314-6. PubMed ID: 7810240
    [Abstract] [Full Text] [Related]

  • 20. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
    van der Straaten RJ, Wessels JA, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Allaart CF, Bogaartz J, Tiller M, Huizinga TW, Guchelaar HJ.
    Pharmacogenomics; 2007 Feb 08; 8(2):141-50. PubMed ID: 17286537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.